var data={"title":"Hydrocortisone (topical): Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Hydrocortisone (topical): Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/389794?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=hydrocortisone-topical-drug-information\" class=\"drug drug_general\">see &quot;Hydrocortisone (topical): Drug information&quot;</a> and <a href=\"topic.htm?path=hydrocortisone-topical-patient-drug-information\" class=\"drug drug_patient\">see &quot;Hydrocortisone (topical): Patient drug information \t&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116177\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Advanced Allergy Collection;</li>\n      <li>Ala Scalp;</li>\n      <li>Ala-Cort;</li>\n      <li>Anti-Itch Maximum Strength [OTC];</li>\n      <li>Anucort-HC;</li>\n      <li>Anusol-HC;</li>\n      <li>Aquanil HC [OTC];</li>\n      <li>Beta HC [OTC];</li>\n      <li>Colocort;</li>\n      <li>Cortaid Maximum Strength [OTC];</li>\n      <li>Cortenema;</li>\n      <li>Corticool [OTC] [DSC];</li>\n      <li>Cortifoam;</li>\n      <li>Dermasorb HC;</li>\n      <li>First-Hydrocortisone;</li>\n      <li>GRx HiCort 25 [DSC];</li>\n      <li>Hemmorex-HC;</li>\n      <li>Hemril-30 [DSC];</li>\n      <li>Hydro Skin Maximum Strength [OTC] [DSC];</li>\n      <li>Hydrocortisone in Absorbase;</li>\n      <li>Hydrocortisone Max St [OTC];</li>\n      <li>Hydrocortisone Max St/12 Moist [OTC];</li>\n      <li>HydroSKIN [OTC];</li>\n      <li>Instacort 5 [OTC];</li>\n      <li>Locoid;</li>\n      <li>Locoid Lipocream;</li>\n      <li>Med-Derm Hydrocortisone [OTC] [DSC];</li>\n      <li>Medi-First Hydrocortisone [OTC];</li>\n      <li>MiCort-HC;</li>\n      <li>NuCort;</li>\n      <li>NuZon [DSC];</li>\n      <li>Pandel;</li>\n      <li>Pediaderm HC [DSC];</li>\n      <li>Preparation H Hydrocortisone [OTC];</li>\n      <li>Procto-Med HC;</li>\n      <li>Procto-Pak;</li>\n      <li>Proctocort;</li>\n      <li>Proctosol HC;</li>\n      <li>Proctozone-HC;</li>\n      <li>Recort Plus [OTC];</li>\n      <li>Rectacort-HC [DSC];</li>\n      <li>Rederm [OTC] [DSC];</li>\n      <li>Sarnol-HC [OTC];</li>\n      <li>Scalacort;</li>\n      <li>Scalacort DK;</li>\n      <li>Scalpicin Maximum Strength [OTC];</li>\n      <li>Texacort;</li>\n      <li>TheraCort [OTC] [DSC];</li>\n      <li>Westcort</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116178\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Aquacort;</li>\n      <li>Cortamed;</li>\n      <li>Cortenema;</li>\n      <li>Cortifoam;</li>\n      <li>Emo-Cort;</li>\n      <li>Hycort;</li>\n      <li>Hyderm;</li>\n      <li>HydroVal;</li>\n      <li>Locoid;</li>\n      <li>Prevex HC;</li>\n      <li>Sarna HC;</li>\n      <li>Westcort</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10495573\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Anti-inflammatory Agent</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Anti-inflammatory Agent, Rectal</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Corticosteroid, Rectal</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Corticosteroid, Topical</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Glucocorticoid</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10495727\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=hydrocortisone-topical-drug-information\" class=\"drug drug_general\">see &quot;Hydrocortisone (topical): Drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Atopic dermatitis:</b> Infants &ge;3 months, Children, and Adolescents: Hydrocortisone butyrate (Locoid Lipocream, Locoid lotion): Topical:  Apply a thin film to affected area twice daily; if no improvement within 2 weeks, reassess diagnosis. </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Corticosteroid-responsive dermatosis (including psoriasis):</b> Infants, Children, and Adolescents: Hydrocortisone base (cream, ointment), hydrocortisone acetate (2% lotion): Topical: Apply a thin film to affected area 2 to 4 times daily depending on the severity of the condition; may use occlusive dressings to manage psoriasis or recalcitrant conditions</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Dermatologic irritation, minor:</b> OTC Labeling: Children &ge;2 years and Adolescents: Hydrocortisone base: Topical: Apply to affected area up to 3 to 4 times daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Anal and genital itching, external:</b> OTC labeling: Children &ge;12 years and Adolescents: Hydrocortisone base: Topical: Apply to affected area up to 3 to 4 times daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Ulcerative colitis, mild to moderate (induction)</b> (Baldassano 1999; Bianchi Porro 1995; ECCO/ESPGHAN [Turner 2012]; NICE 2013; Regan 2014): Children and Adolescents: Limited data available: Rectal enema/suspension: Rectal: One enema (100 mg) once or twice daily (Baldassano 1999). Once daily administration in the evening for 3 weeks was used in 52 adolescent and adult patients (age range: 16 to 67 years) in a randomized, double blind study comparing hydrocortisone enemas to rectal suspension of 5-aminosalicylic acid (Bianchi Porro 1995) </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Corticosteroid responsive dermatosis:</b> Topical:  </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Hydrocortisone base: Apply thin film to affected area 3 to 4 times daily</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Hydrocortisone butyrate (Locoid cream, Lipocream, ointment, solution): Apply thin film to affected area 2 to 3 times daily</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Hydrocortisone probutate (Pandel): Topical: Apply thin film to affected area 1 to 2 times daily</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Hydrocortisone valerate (Westcort): Topical: Apply thin film to affected area 2 to 3 times daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Anal and genital itching, external:</b> OTC labeling: Topical: Apply to affected area up to 3 to 4 times daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Hemorrhoids:</b> Rectal: One suppository (25 or 30 mg) twice daily for 2 weeks. For severe cases of proctitis, 1 suppository 3 times daily or 2 suppositories twice daily may be needed. For factitial proctitis, duration of treatment may be up to 6 to 8 weeks.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Ulcerative colitis:</b> Rectal: </p>\n    <p style=\"text-indent:-4em;margin-left:8em;\">Enema/Suspension: One enema (100 mg) every night for 21 days or until remission (clinical improvement may precede improvement of mucosal integrity); 2 to 3 months of therapy may be required; to discontinue long-term therapy, gradually reduce administration to every other night for 2 or 3 weeks</p>\n    <p style=\"text-indent:-4em;margin-left:8em;\">Foam: One applicatorful (90 mg) 1 to 2 times daily for 2 to 3 weeks, and then every other day thereafter; use lowest dose to maintain clinical response; taper dose to discontinue long-term therapy</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in renal impairment:</b> There are no dosage adjustments provided in the manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in hepatic impairment:</b> There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116386\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, External, as acetate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">MiCort-HC: 2.5% (4 g, 28.4 g) [contains butylparaben, cetostearyl alcohol, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, External, as base: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ala-Cort: 1% (28.4 g, 85.2 g [DSC]); 2.5% (30 g) [contains cetyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Anti-Itch Maximum Strength: 1% (28 g) [contains cetyl alcohol, methylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Anti-Itch Maximum Strength: 1% (28 g) [contains cetyl alcohol, methylparaben, propylene glycol, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cortaid Maximum Strength: 1% (14 g [DSC], 28 g) [contains cetyl alcohol, disodium edta, ethylparaben, methylparaben, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Hydrocortisone Max St: 1% (28.4 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Hydrocortisone Max St/12 Moist: 1% (28.4 g) [contains cetearyl alcohol, methylparaben, propylene glycol, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">HydroSKIN: 1% (28 g [DSC]) [contains benzyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">HydroSKIN: 1% (28 g) [contains methylparaben, propylene glycol, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Instacort 5: 0.5% (28.4 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Med-Derm Hydrocortisone: 0.5% (30 g [DSC]); 1% (30 g [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Medi-First Hydrocortisone: 1% (1 ea) [contains trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Preparation H Hydrocortisone: 1% (26 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Recort Plus: 1% (30 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.5% (15 g, 28.35 g, 28.4 g); 1% (1 g, 1.5 g, 14.2 g, 20 g, 28 g, 28.35 g, 28.4 g, 30 g, 120 g [DSC], 453.6 g, 454 g); 2.5% (20 g, 28 g, 28.35 g, 30 g, 453.6 g, 454 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, Rectal, as base: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Anusol-HC: 2.5% (30 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Procto-Med HC: 2.5% (30 g) [contains cetearyl alcohol, methylparaben, propylene glycol, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Procto-Pak: 1% (28.4 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Proctocort: 1% (28.35 g) [contains cetyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Proctosol HC: 2.5% (28.35 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Proctozone-HC: 2.5% (30 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Proctozone-HC: 2.5% (30 g) [contains cetearyl alcohol, methylparaben, propylene glycol, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (28.4 g); 2.5% (30 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, External, as butyrate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Locoid: 0.1% (15 g, 45 g) [contains butylparaben, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Locoid Lipocream: 0.1% (45 g, 60 g) [contains butylparaben, cetostearyl alcohol, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.1% (15 g, 45 g, 60 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, External, as probutate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Pandel: 0.1% (45 g [DSC], 80 g) [contains butylparaben, methylparaben, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, External, as valerate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.2% (15 g, 45 g, 60 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Enema, Rectal, as base: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Colocort: 100 mg/60 mL (60 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cortenema: 100 mg/60 mL (60 mL) [contains methylparaben, polysorbate 80]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 100 mg/60 mL (60 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Foam, Rectal, as acetate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cortifoam: 10% [90 mg/applicatorful] (15 g) [contains cetyl alcohol, methylparaben, propylene glycol, propylparaben, trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gel, External, as acetate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">NuZon: 2% (43 g [DSC]) [contains menthol, trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 2% (43 g [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gel, External, as base: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Corticool: 1% (42.53 g [DSC]) [contains cremophor el, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">First-Hydrocortisone: 10% (60 g) [contains propylene glycol, simethicone]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Kit, External, as base: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Advanced Allergy Collection: 2.5% [contains cetyl alcohol, methylparaben, propylene glycol, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Dermasorb HC: 2% [contains menthol, methylparaben, propylene glycol, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Pediaderm HC: 2% [DSC] [contains benzalkonium chloride, cetyl alcohol, isopropyl alcohol, methylparaben, propylene glycol, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Scalacort DK: Hydrocortisone lotion 2% and Sal Acid 2% and sulfur 2% [contains benzalkonium chloride, isopropyl alcohol, methylparaben, propylene glycol, propylparaben, soybean lecithin]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Lotion, External, as acetate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">NuCort: 2% (60 g) [contains benzyl alcohol, cetyl alcohol, menthol, trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Lotion, External, as base: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ala Scalp: 2% (29.6 mL) [contains benzalkonium chloride, isopropyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Aquanil HC: 1% (120 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Beta HC: 1% (60 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Hydro Skin Maximum Strength: 1% (118 mL [DSC]) [contains benzyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">HydroSKIN: 1% (118 mL) [contains benzyl alcohol, cetyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Rederm: 1% (120 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Sarnol-HC: 1% (59 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Scalacort: 2% (29.6 mL) [contains benzalkonium chloride, isopropyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">TheraCort: 1% (118 mL [DSC]) [contains methylparaben, propylene glycol, propylparaben, trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (114 g); 2.5% (59 mL, 118 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Lotion, External, as butyrate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Locoid: 0.1% (59 mL, 118 mL) [contains butylparaben, cetostearyl alcohol, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.1% (59 mL, 118 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Ointment, External, as base: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Hydrocortisone in Absorbase: 1% (110 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.5% (28.35 g, 30 g); 2.5% (20 g, 28.35 g, 453.6 g, 454 g); 1% (25 g [DSC], 28 g, 28.35 g, 28.4 g, 30 g, 110 g [DSC], 430 g [DSC], 453.6 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Ointment, External, as butyrate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Locoid: 0.1% (15 g, 45 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.1% (15 g, 45 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Ointment, External, as valerate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Westcort: 0.2% (15 g, 45 g, 60 g) [contains propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.2% (15 g, 45 g, 60 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, External, as base: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Scalpicin Maximum Strength: 1% (44 mL) [contains disodium edta, menthol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Texacort: 2.5% (30 mL) [lipid free, paraben free; contains alcohol, usp]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, External, as butyrate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Locoid: 0.1% (60 mL) [contains isopropyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.1% (20 mL, 60 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Suppository, Rectal, as acetate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Anucort-HC: 25 mg (1 ea, 12 ea, 24 ea, 100 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Anusol-HC: 25 mg (12 ea, 24 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">GRx HiCort 25: 25 mg (12 ea [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Hemmorex-HC: 25 mg (12 ea, 24 ea); 30 mg (12 ea [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Hemril-30: 30 mg (12 ea [DSC], 24 ea [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Proctocort: 30 mg (12 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Rectacort-HC: 25 mg (12 ea [DSC], 24 ea [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 25 mg (12 ea, 24 ea, 100 ea); 30 mg (12 ea)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116182\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45039957\" class=\"block dosfc drugH1Div\"><span class=\"drugH1\">Dosage Forms Considerations</span><p>(For additional information <a href=\"topic.htm?path=hydrocortisone-topical-drug-information\" class=\"drug drug_general\">see &quot;Hydrocortisone (topical): Drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">First-Hydrocortisone 10% gel is a compounding kit. Refer to manufacturer's labeling for compounding instructions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10495728\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical preparations: For external use only; avoid contact with the eyes. Shake lotion well before use. Apply a thin film to clean, dry skin and rub in gently. Do not apply to face, underarms, or groin unless directed by physician. Do not wrap or bandage affected area unless directed by physician. Do not apply to diaper areas because diapers or plastic pants may be occlusive. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rectal foam: Shake vigorously for 5 to 10 seconds prior to use. Do not remove cap during use. Hold container upright to fill applicator. Gently insert applicator tip into anus. Only use applicator provided by manufacturer; do not insert any part of the aerosol container in the anus. Clean applicator after each use with warm water.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rectal suppository: Remove foil from rectal suppository and insert pointed end first. Avoid handling unwrapped suppository for too long.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rectal enema/suspension: Shake bottle well. Remove protective sheath from applicator tip. Lie on left side with left leg extended and right leg flexed forward. Gently insert lubricated applicator tip into rectum, pointed slightly toward navel. Grasp bottle firmly and squeeze slowly to instill the medication. After administering, withdraw and discard the used unit. Remain in position for at least 30 minutes. Retain the enema all night if possible.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116289\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F). Protect from heat and freezing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Foam: Contents are under pressure; do not burn or puncture the container; do not store at temperatures above 48.9&deg;C (120&deg;F).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10495574\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical formulations:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hydrocortisone base: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses (FDA approved in pediatric patients [age not specified] and adults)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">OTC products (cream, lotion, ointment): Temporary relief of itching associated with minor skin irritations, inflammation, and rashes (eg, eczema; psoriasis; poison ivy, oak, or sumac; insect bites; minor skin irritation; seborrheic dermatitis) (FDA approved in ages &ge;2 years and adults); temporary relief of external anal and genital itching (FDA approved in ages &ge;12 years and adults). <b>Note:</b> Approved indications and ages may vary by product; consult product specific labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hydrocortisone acetate lotion: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses (FDA approved in pediatric patients [age not specified] and adults)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hydrocortisone butyrate: Treatment of mild to moderate atopic dermatitis (Cream: FDA approved in pediatric patients &ge;3 months; Lotion:  FDA approved in ages &ge; 3 months and adults); relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses (Cream: FDA approved in adults)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hydrocortisone probutate cream: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses (FDA approved in ages &ge;18 years and adults)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hydrocortisone valerate cream: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses (FDA approved in adults)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rectal formulations:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Enema/suspension: Adjunctive therapy in the treatment of ulcerative colitis, especially distal forms, including ulcerative proctitis, ulcerative proctosigmoiditis, and left-sided ulcerative colitis (FDA approved in adults)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Foam: Adjunctive therapy for topical treatment of ulcerative proctitis of the distal rectum in patients who cannot retain enemas (FDA approved in adults)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Suppository: Treatment of inflamed hemorrhoids, postirradiation (factitial) proctitis; as an adjunct in the treatment of chronic ulcerative colitis, cryptitis, and other inflammatory conditions of anorectum and pruritus ani (All indications: FDA approved in adults)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116165\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Hydrocortisone may be confused with hydrocodone, hydroxychloroquine, hydrochlorothiazide</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Anusol may be confused with Anusol-HC, Aplisol, Aquasol</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cortizone may be confused with cortisone</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">HCT (occasional abbreviation for hydrocortisone) is an error-prone abbreviation (mistaken as hydrochlorothiazide)</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Hytone may be confused with Vytone</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Proctocort may be confused with ProctoCream</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">International issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Nutracort [multiple international markets] may be confused with Nitrocor brand name of nitroglycerin [Italy, Russia, and Venezuela]</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116264\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Local adverse events presented. Adverse events similar to those observed with systemic absorption are also observed, especially following rectal use. Refer to the Hydrocortisone (Systemic) monograph for details.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Cream, ointment:</b> Dermatologic: Acneiform eruption, atrophic striae, burning sensation of skin, folliculitis, hypertrichosis, hypopigmentation, maceration of the skin, miliaria, perioral dermatitis, pruritus, secondary skin infection, skin atrophy, skin irritation, xeroderma</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Enema:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Central nervous system: Localized burning</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hematologic &amp; oncologic: Rectal hemorrhage</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Local: Local pain</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Suppositories:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Central nervous system: Localized burning</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dermatologic: Allergic contact dermatitis, folliculitis, hypopigmentation, pruritus, xeroderma</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infection: Secondary infection</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116259\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hypersensitivity to hydrocortisone or any component of the formulation; systemic fungal infections and ileocolostomy during the immediate or early postoperative period (rectal suspension); obstruction, abscess, perforation, peritonitis, fresh intestinal anastomoses, extensive fistulas, and sinus tracts (rectal foam).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">OTC labeling: When used for self-medication, do not use for the treatment of diaper dermatitis.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">Documentation of allergenic cross-reactivity for corticosteroids is limited. However, because of similarities in chemical structure and/or pharmacologic actions, the possibility of cross-sensitivity cannot be ruled out with certainty.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116260\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Adrenal suppression: May cause hypercortisolism or suppression of hypothalamic-pituitary-adrenal (HPA) axis, particularly in younger children or in patients receiving high doses for prolonged periods. HPA axis suppression may lead to adrenal crisis.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Anaphylactoid reactions: Rare cases of anaphylactoid reactions have been observed in patients receiving corticosteroids.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Contact dermatitis: Allergic contact dermatitis can occur and is usually diagnosed by failure to heal rather than clinical exacerbation; discontinue use if irritation occurs and treat appropriately.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Immunosuppression: Prolonged use of corticosteroids may increase the incidence of secondary infection, mask acute infection (including fungal infections), prolong or exacerbate viral infections, or limit response to vaccines. Exposure to chickenpox or measles should be avoided; corticosteroids should not be used to treat ocular herpes simplex. Corticosteroids should not be used for cerebral malaria, fungal infections, or viral hepatitis. Close observation is required in patients with latent tuberculosis and/or tuberculosis reactivity; restrict use in active tuberculosis (only fulminating or disseminated tuberculosis in conjunction with antituberculosis treatment). Amebiasis should be ruled out in any patient with recent travel to tropical climates or unexplained diarrhea prior to initiation of corticosteroids.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Kaposi sarcoma: Prolonged treatment with corticosteroids has been associated with the development of Kaposi sarcoma (case reports); if noted, discontinuation of therapy should be considered (Goedert 2002).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Myopathy: Acute myopathy has been reported with high-dose corticosteroids, usually in patients with neuromuscular transmission disorders; may involve ocular and/or respiratory muscles; monitor creatine kinase; recovery may be delayed.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Psychiatric disturbances: Corticosteroid use may cause psychiatric disturbances, including depression, euphoria, insomnia, mood swings, and personality changes. Preexisting psychiatric conditions may be exacerbated by corticosteroid use.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Sensitization: Topical use has been associated with local sensitization (redness, irritation); discontinue if sensitization is noted.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Systemic effects: Topical corticosteroids may be absorbed percutaneously. Absorption of topical corticosteroids may cause manifestations of Cushing syndrome, hyperglycemia, or glycosuria. Absorption is increased by the use of occlusive dressings, application to denuded skin, prolonged use, or application to large surface areas.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Cardiovascular disease: Use with caution in patients with heart failure and/or hypertension.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Diabetes: Use with caution in patients with diabetes mellitus.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Gastrointestinal disease: Use with caution in patients with GI diseases (diverticulitis, intestinal anastomoses, peptic ulcer, nonspecific ulcerative colitis).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hepatic impairment: Use with caution in patients with hepatic impairment, including cirrhosis.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Myasthenia gravis: Use with caution in patients with myasthenia gravis.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Myocardial infarction: Use with caution following acute myocardial infarction (MI); corticosteroids have been associated with myocardial rupture.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Ocular disease: Use with caution in patients with cataracts and/or glaucoma; increased intraocular pressure, glaucoma, and cataracts have occurred with prolonged use.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Osteoporosis: Use with caution in patients with osteoporosis.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Renal impairment: Use with caution in patients with renal impairment; fluid retention may occur.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Thyroid disease: Use caution with thyroid disease. Changes in thyroid status may necessitate dosage adjustments; metabolic clearance of corticosteroids increases in hyperthyroid patients and decreases in hypothyroid ones.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Ulcerative colitis: With severe ulcerative colitis, it may be hazardous to delay surgery while waiting for response to treatment.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Elderly: Because of the risk of adverse effects associated with systemic absorption, topical corticosteroids should be used cautiously in elderly patients in the smallest possible effective dose for the shortest duration.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pediatric: Children may absorb proportionally larger amounts after topical application and may be more prone to systemic effects. HPA axis suppression, intracranial hypertension, and Cushing syndrome have been reported in children receiving topical corticosteroids. Prolonged use may affect growth velocity; growth should be routinely monitored in pediatric patients.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: Avoid use of topical preparations with occlusive dressings or on weeping or exudative lesions. Not for treatment of diaper dermatitis.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol: Some dosage forms may contain benzyl alcohol and/or sodium benzoate/benzoic acid; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol and/or benzyl alcohol derivative with caution in neonates. See manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Rectal enema: Damage to the rectal wall may occur from improper or careless insertion of the enema tip. Use with caution when there is a probability of impending perforation, abscess, or other pyogenic infection; obstruction; or extensive fistulas and sinus tracts.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Rectal foam: Do not insert any part of the aerosol container directly into the anus. Contents are under pressure; do not burn or puncture the container; do not store at temperatures above 48.9&deg;C (120&deg;F). If there is not evidence of clinical or proctologic improvement within 2 or 3 weeks after initiation of therapy, or if the condition worsens, discontinue use. Contraindicated in obstruction, abscess, perforation, peritonitis, fresh intestinal anastomoses, extensive fistulas, and sinus tracts.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Discontinuation of therapy: After long-term use, withdraw therapy with gradual tapering of dose.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Self-medication (OTC use): Contact health care provider if condition worsens, symptoms persist for &gt;7 days, or rectal bleeding occurs.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Stress: May require higher doses when subject to stress (ie, trauma, surgery, severe infection).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26022591\" class=\"block add-pediatric-warn-info drugH1Div\"><span class=\"drugH1\">Warnings: Additional Pediatric Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">The extent of percutaneous absorption is dependent on several factors, including epidermal integrity (intact vs abraded skin), formulation, age of the patient, prolonged duration of use, and the use of occlusive dressings. Percutaneous absorption of topical steroids is increased in neonates (especially preterm neonates), infants, and young children. Infants and small children may be more susceptible to HPA axis suppression, intracranial hypertension, Cushing syndrome, or other systemic toxicities due to larger skin surface area to body mass ratio.   </p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116282\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Substrate</b> of CYP3A4 (minor); <b>Note:</b> Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116283\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=16000&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Aldesleukin: Corticosteroids may diminish the antineoplastic effect of Aldesleukin. <i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ceritinib: Corticosteroids may enhance the hyperglycemic effect of Ceritinib. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Corticorelin: Corticosteroids may diminish the therapeutic effect of Corticorelin. Specifically, the plasma ACTH response to corticorelin may be blunted by recent or current corticosteroid therapy. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Deferasirox: Corticosteroids may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hyaluronidase: Corticosteroids may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving corticosteroids (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ritodrine: Corticosteroids may enhance the adverse/toxic effect of Ritodrine. <i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116254\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116255\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse events have been observed in some animal reproduction studies.</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Systemic bioavailability of topical corticosteroids is variable (integrity of skin, use of occlusion, etc.) and may be further influenced by trimester of pregnancy (Chi 2017). In general, the use of topical corticosteroids is not associated with a significant risk of adverse pregnancy outcomes. However, there may be an increased risk of low birth weight infants following maternal use of potent or very potent topical products, especially in high doses. Use of mild to moderate potency topical corticosteroids is preferred in pregnant females and the use of large amounts or use for prolonged periods of time should be avoided (Chi 2016; Chi 2017; Murase 2014). Also avoid areas of high percutaneous absorption (Chi 2017). The risk of stretch marks may be increased with use of topical corticosteroids (Murase 2014).</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">The treatment of psoriasis in pregnancy is initiated with conservative treatment as in nonpregnant females. When a topical steroid is needed, low to moderate potency corticosteroids are preferred initially. High potency topical steroids should be used only when clearly needed and after the first trimester (Bae 2012).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10495729\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Growth in pediatric patients; assess HPA axis suppression in patients using topical steroids applied to a large surface area or to areas under occlusion (eg, ACTH stimulation test, morning plasma cortisol test, urinary free cortisol test).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116313\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Topical corticosteroids have anti-inflammatory, antipruritic, and vasoconstrictive properties. May depress the formation, release, and activity of endogenous chemical mediators of inflammation (kinins, histamine, liposomal enzymes, prostaglandins) through the induction of phospholipase A<sub>2</sub> inhibitory proteins (lipocortins) and sequential inhibition of the release of arachidonic acid. Hydrocortisone has low to intermediate range potency (dosage-form dependent).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116319\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Topical corticosteroids are absorbed percutaneously. The extent is dependent on several factors, including epidermal integrity (intact  vs abraded skin),  formulation, and the use of occlusive dressings.  Percutaneous absorption of topical steroids is increased in neonates (especially preterm neonates), infants, and young children. Rectal absorption is more substantial than most topical preparations; therefore, systemic effects are more common.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: Hepatic</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine (major); bile</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8116388\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Anusol-HC Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5% (30 g): $155.32</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Cortaid Maximum Strength External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (28 g): $3.92</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Hydrocortisone Butyr Lipo Base External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (45 g): $384.43</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Hydrocortisone Butyrate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (45 g): $188.46</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Hydrocortisone External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.5% (28.35 g): $3.24</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (28.35 g): $4.80</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5% (20 g): $6.60</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Hydrocortisone Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (28.4 g): $60.00</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5% (30 g): $83.16</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Hydrocortisone Valerate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.2% (45 g): $180.50</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (HydroSKIN External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (28 g): $2.85</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Locoid External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (15 g): $142.92</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Locoid Lipocream External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (45 g): $902.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (MiCort-HC External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5% (4 g): $12.38</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Pandel External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (80 g): $1,287.23</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Preparation H Hydrocortisone External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (26 g): $6.73</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Procto-Med HC Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5% (30 g): $87.33</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Procto-Pak Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (28.4 g): $48.95</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Proctocort Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (28.35 g): $735.16</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Proctosol HC Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5% (28.35 g): $87.33</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Proctozone-HC Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5% (30 g): $87.33</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Enema</b> (Colocort Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100 mg/60 mL (60 mL): $12.65</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Enema</b> (Cortenema Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100 mg/60 mL (60 mL): $17.75</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Enema</b> (Hydrocortisone Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100 mg/60 mL (60 mL): $10.67</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Foam</b> (Cortifoam Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10% (15 g): $477.84</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (First-Hydrocortisone External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10% (60 g): $132.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Advanced Allergy Collection External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5% (1): $882.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Dermasorb HC External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (295.8 mL): $621.60</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Scalacort DK External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2 &amp; 2-2% (265.6 mL): $97.20</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (Ala Scalp External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (29.6 mL): $509.83</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (Aquanil HC External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (120 mL): $14.70</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (Hydrocortisone Butyrate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (59 mL): $482.50</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (Hydrocortisone External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (114 g): $6.56</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5% (59 mL): $52.03</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (HydroSKIN External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (118 mL): $9.15</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (Locoid External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (59 mL): $632.16</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (NuCort External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (60 g): $300.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (Sarnol-HC External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (59 mL): $9.84</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Hydrocortisone Butyrate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (15 g): $57.30</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Hydrocortisone External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.5% (28.35 g): $3.96</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (28 g): $3.48</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5% (28.35 g): $11.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Hydrocortisone in Absorbase External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (110 g): $1,425.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Hydrocortisone Valerate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.2% (45 g): $198.37</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Locoid External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (15 g): $136.20</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Westcort External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.2% (45 g): $156.48</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Hydrocortisone Butyrate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (60 mL): $229.42</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Locoid External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (60 mL): $544.82</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Scalpicin Maximum Strength External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (44 mL): $6.54</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Texacort External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5% (30 mL): $222.29</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (Anusol-HC Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">25 mg (12): $691.54</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (Hemmorex-HC Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">25 mg (12): $570.98</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (Hydrocortisone Acetate Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">25 mg (12): $271.76</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">30 mg (12): $205.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (Proctocort Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">30 mg (12): $817.15</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10961980\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Alfacort (AE, AR, BH, JO, KW, QA, SA);</li>\n      <li>Alfason (DE);</li>\n      <li>Allerderm (ZW);</li>\n      <li>Biocort (ZA);</li>\n      <li>Calmiox (ES);</li>\n      <li>Calmurid (CL);</li>\n      <li>Colifoam (AU, GR);</li>\n      <li>Cort Dome (CO, EC);</li>\n      <li>Cortaid Cream (AU);</li>\n      <li>Cortic-DS (AU);</li>\n      <li>Cortider (BD);</li>\n      <li>Cortiderm (AE, BH, KW, QA, SA);</li>\n      <li>Cortileb (ET);</li>\n      <li>Cortopin (IE);</li>\n      <li>Delster (HK);</li>\n      <li>Derm-Aid (AE, CY);</li>\n      <li>Dermacrin HC Lotion (KR);</li>\n      <li>Dermocare (KR);</li>\n      <li>Dervacort (ZW);</li>\n      <li>DHAcort (HK, MY);</li>\n      <li>Dilucort (ZA);</li>\n      <li>Dioderm (IE);</li>\n      <li>Eczacort (PH);</li>\n      <li>Efcortelan (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);</li>\n      <li>Efficort (TH);</li>\n      <li>Egocort (AE);</li>\n      <li>Hc45 (IE);</li>\n      <li>Hidrotisona (AR);</li>\n      <li>Hikomicron (HU);</li>\n      <li>Hipoge (CL);</li>\n      <li>Hovicor (PH);</li>\n      <li>Hydcort (KR);</li>\n      <li>Hyde (KR);</li>\n      <li>Hydracort (LB, VN);</li>\n      <li>Hydrocort (BD, JO, KW, LK, SG);</li>\n      <li>Hydrocortisyl (IE);</li>\n      <li>Hydroderm (SG);</li>\n      <li>Hydrokortison (EE);</li>\n      <li>Hydrosone (LK);</li>\n      <li>Hydrotopic (PH);</li>\n      <li>Hysone (PK);</li>\n      <li>Hytisone (TH);</li>\n      <li>Hytone Lotion (KR);</li>\n      <li>Intasone (BD);</li>\n      <li>Lacticare HC (PH);</li>\n      <li>Lacticare-HC (VN);</li>\n      <li>Lactisona (ES);</li>\n      <li>Laticort (BG, HN, LV, PL);</li>\n      <li>Latycort (UA);</li>\n      <li>Lexacorton (ID);</li>\n      <li>Locoid (AE, BB, BE, BH, BR, CH, CL, CN, CR, CY, CZ, DK, DO, EG, FI, FR, GB, GT, HN, HU, IE, IQ, IR, IS, JO, KW, LB, LU, LY, MT, NI, NL, NO, NZ, OM, PA, PE, PL, PT, QA, RO, RU, SA, SE, SK, SV, SY, TR, TW, VN, YE);</li>\n      <li>Locoid Lipo (IN);</li>\n      <li>Locoidon (AT, IT, PE, SI);</li>\n      <li>Lokoyid (UA);</li>\n      <li>Lycor (LK);</li>\n      <li>Medrocil (AR);</li>\n      <li>Mylocort (ZA);</li>\n      <li>Netracort (ET, LK);</li>\n      <li>Nutracort (CO, CR, DO, GT, NI, PA, SV, VE);</li>\n      <li>Nutraderm (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Nutrasona (ES);</li>\n      <li>Pandel (CL, JP, PE, PY, UY);</li>\n      <li>Plancol (KR);</li>\n      <li>Riacort (QA);</li>\n      <li>Sicacort H (ET);</li>\n      <li>Sigmacort (AU, HK);</li>\n      <li>Tarocort (IL);</li>\n      <li>Topicort (LK);</li>\n      <li>Unicort (BD, CO, LK);</li>\n      <li>Westcort (BB, KR);</li>\n      <li>Youzhouer (CN);</li>\n      <li>Zocort (BD);</li>\n      <li>Zona (ET)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/hydrocortisone-topical-pediatric-drug-information/abstract-text/11487763 /pubmed\" target=\"_blank\" id=\"11487763 \">11487763 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    AlaCort (hydrocortisone topical) [prescribing information]. Johnson City, TN: Crown Laboratories; June 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ala-Scalp (hydrocortisone topical) [prescribing information]. Johnson City, TN: Crown Laboratories; January 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics Committee on Drugs. &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/hydrocortisone-topical-pediatric-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Anucort-HC (hydrocortisone topical) [prescribing information]. South Plainfield, NJ: G&amp;W Laboratories; November 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Anusol-HC (hydrocortisone topical) suppositories [prescribing information]. Morrisville, NC: Salix Pharmaceuticals; March 2005.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Baldassano RN, Piccoli DA. Inflammatory bowel disease in pediatric and adolescent patients. <i>Gastroenterol Clin North Am</i>. 1999;28(2):445-458.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/hydrocortisone-topical-pediatric-drug-information/abstract-text/10372276/pubmed\" target=\"_blank\" id=\"10372276\">10372276</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bianchi Porro G, Ardizzone S, Petrillo M, Fasoli A, Molteni P, Imbesi V. Low Pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study. <i>Am J Gastroenterol</i>. 1995;90(5):736-739. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/hydrocortisone-topical-pediatric-drug-information/abstract-text/7733079/pubmed\" target=\"_blank\" id=\"7733079\">7733079</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol--United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982; 31(22):290-291. Available at  http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/hydrocortisone-topical-pediatric-drug-information/abstract-text/6810084/pubmed\" target=\"_blank\" id=\"6810084\">6810084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Chi CC, Kirtschig G, Aberer W, et al. Evidence-based (S3) guideline on topical corticosteroids in pregnancy. <i>Br J Dermatol</i>. 2011;165(5):943-952.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/hydrocortisone-topical-pediatric-drug-information/abstract-text/21729030 /pubmed\" target=\"_blank\" id=\"21729030 \">21729030 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Chi CC, Wang SH, Mayon-White R, Wojnarowska F. Pregnancy outcomes after maternal exposure to topical corticosteroids: a UK population-based cohort study. <i>JAMA Dermatol</i>. 2013;149(11):1274-1280.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/hydrocortisone-topical-pediatric-drug-information/abstract-text/24005903/pubmed\" target=\"_blank\" id=\"24005903\">24005903</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Colocort (hydrocortisone topical) [prescribing information]. Minneapolis, MN: Perrigo; March 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cortenema (hydrocortisone topical) [prescribing information]. Baudette, MN: Ani Pharmaceuticals; November 2011.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cortaid cream (hydrocortisone topical) [prescribing information]. Bridgewater, NJ:  Valeant Pharmaceuticals; January 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cortifoam (hydrocortisone topical) [prescribing information]. Somerset, NJ: Meda Pharmaceuticals; May 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cortizone&bull;10 Children's Cooling Cream With Aloe (hydrocortisone topical) [prescribing information]. Chattanooga, TN: Chattem; 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Goedert JJ, Vitale F, Lauria C, et al. Risk factors for classical Kaposi's sarcoma. <i>J Natl Cancer Inst</i>. 2002;94(22):1712-1718.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/hydrocortisone-topical-pediatric-drug-information/abstract-text/12441327/pubmed\" target=\"_blank\" id=\"12441327\">12441327</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    GRx HiCort (hydrocortisone topical) [prescribing information]. Mount Vernon, NY: Geritrex; November 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hemorrex-HC (hydrocortisone topical) [prescribing information].  Greenville, SC:  Laser Pharmaceuticals, LLC; May 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    HydroSKIN lotion (hydrocortisone topical) [prescribing information]. Duluth, GA: Rugby; January 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    HydroSKIN Maximum Strength cream (hydrocortisone topical) [prescribing information]. Duluth, GA: Rugby; March 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Leachman SA, Reed BR. The use of dermatologic drugs in pregnancy and lactation. <i>Dermatol Clin</i>. 2006;24(2):167-197, vi.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/hydrocortisone-topical-pediatric-drug-information/abstract-text/16677965 /pubmed\" target=\"_blank\" id=\"16677965 \">16677965 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Locoid (hydrocortisone topical) lotion [prescribing information]. Bridgewater, NJ: Valeant Pharmaceuticals; October 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Locoid Lipocream (hydrocortisone topical) [prescribing information]. Ferndale, MI: Triax Pharmaceuticals; October 2009. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    NICE. Management of atopic eczema in children from birth up to the age of 12 years. Clinical guideline. December 2007. Available at http://www.nice.org.uk/guidance/cg57/evidence/full-guideline-196612237</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    NICE. Ulcerative colitis: management. Clinical guideline. June 2013. Available at https://www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-35109695126725</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Pandel (hydrocortisone topical) [prescribing information]. Melville, NY: Pharmaderm; December 2008.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Proctocort (hydrocortisone topical) suppositories [prescribing information]. Morrisville, NC: Salix Pharmaceuticals; March 2005.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Proctosol HC (hydrocortisone topical) [prescribing information]. Jacksonville, FL: Ranbaxy Laboratories; February 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Proctozone HC (hydrocortisone topical) [prescribing information]. Allendale, NJ: Rising Pharmaceuticals; December 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Rectacort HC (hydrocortisone topical) [prescribing information]. Hamilton, NJ: Acino Products; March 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Reed, BR, &ldquo;Dermatologic Drugs, Pregnancy, and Lactation. A Conservative Guide,&rdquo; <i>Arch Dermatol</i>, 1997, 133(7):894-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/hydrocortisone-topical-pediatric-drug-information/abstract-text/9236528/pubmed\" target=\"_blank\" id=\"9236528\">9236528</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Regan BP, Bousvaros A. Pediatric ulcerative colitis: a practical guide to management. <i>Paediatr Drugs</i>. 2014;16(3):189-198.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/hydrocortisone-topical-pediatric-drug-information/abstract-text/19188870/pubmed\" target=\"_blank\" id=\"19188870\">19188870</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Texacort (hydrocortisone topical) [prescribing information]. San Anonio, TX: Mission; March 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Turner D, Levine A, Escher JC, et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. <i>J Pediatr Gastroenterol Nutr</i>. 2012;55(3):340-361.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/hydrocortisone-topical-pediatric-drug-information/abstract-text/22773060 /pubmed\" target=\"_blank\" id=\"22773060 \">22773060 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Westcort (hydrocortisone topical) [prescribing information]. Princeton, NJ: Westwood-Squibb Pharmaceuticals; April, 2006.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 16000 Version 243.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F8116177\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F8116178\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F10495573\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F10495727\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F8116386\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F8116182\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms Considerations\" href=\"#F45039957\" class=\"outlineLink\">Dosage Forms Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F10495728\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F8116289\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F10495574\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F8116165\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F8116264\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F8116259\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F8116260\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings: Additional Pediatric Considerations\" href=\"#F26022591\" class=\"outlineLink\">Warnings: Additional Pediatric Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F8116282\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F8116283\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F8116254\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F8116255\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F10495729\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F8116313\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F8116319\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F8116388\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F10961980\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/16000|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=hydrocortisone-topical-drug-information\" class=\"drug drug_general\">Hydrocortisone (topical): Drug information</a></li><li><a href=\"topic.htm?path=hydrocortisone-topical-patient-drug-information\" class=\"drug drug_patient\">Hydrocortisone (topical): Patient drug information \t</a></li></ul></div></div>","javascript":null}